We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$16.8B
AUM Growth
+$1.95B
Cap. Flow
+$1.49B
Cap. Flow %
8.85%
Top 10 Hldgs %
30.31%
Holding
2,964
New
179
Increased
2,266
Reduced
433
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$118M
2
AAPL icon
Apple
AAPL
+$96.6M
3
NVDA icon
NVIDIA
NVDA
+$91.2M
4
AMZN icon
Amazon
AMZN
+$67.2M
5
META icon
Meta Platforms (Facebook)
META
+$38.6M

Sector Composition

Rank Sector Weight
1 Technology 30.48%
2 Financials 11.78%
3 Healthcare 11.37%
4 Consumer Discretionary 10.49%
5 Industrials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VECO icon
1126
Veeco
VECO
$3.28B
$1.5M 0.01%
32,075
+5,510
+21% +$218K
KOS icon
1127
Kosmos Energy
KOS
$1.51B
$1.5M 0.01%
270,101
+37,203
+16% +$217K
PRFT
1128
DELISTED
Perficient Inc
PRFT
$1.5M 0.01%
20,000
+2,566
+15% +$164K
AZTA icon
1129
Azenta
AZTA
$1.49B
$1.49M 0.01%
28,407
-2,211
-7% -$118K
SAM icon
1130
Boston Beer
SAM
$1.9B
$1.49M 0.01%
4,900
-630
-11% -$180K
MGRC icon
1131
McGrath RentCorp
MGRC
$2.94B
$1.49M 0.01%
14,019
+1,311
+10% +$144K
NARI
1132
DELISTED
Inari Medical, Inc. Common Stock
NARI
$1.49M 0.01%
30,903
-16,956
-35% -$752K
SWTX
1133
DELISTED
SpringWorks Therapeutics
SWTX
$1.48M 0.01%
39,387
+4,467
+13% +$188K
BIO icon
1134
Bio-Rad Laboratories Class A
BIO
$9.66B
$1.48M 0.01%
5,422
+529
+11% +$154K
MQ icon
1135
Marqeta
MQ
$1.71B
$1.48M 0.01%
67,524
+7,716
+13% +$170K
RUSHA icon
1136
Rush Enterprises Class A
RUSHA
$9.62B
$1.47M 0.01%
35,129
+3,441
+11% +$158K
PJT icon
1137
PJT Partners
PJT
$4.57B
$1.47M 0.01%
13,614
+1,693
+14% +$170K
LCII icon
1138
LCI Industries
LCII
$2.6B
$1.46M 0.01%
14,140
+1,506
+12% +$163K
PFSI icon
1139
PennyMac Financial
PFSI
$4.13B
$1.46M 0.01%
15,424
+2,657
+21% +$240K
ARCB icon
1140
ArcBest
ARCB
$3.28B
$1.46M 0.01%
13,601
+1,516
+13% +$183K
ADMA icon
1141
ADMA Biologics
ADMA
$2.11B
$1.46M 0.01%
130,152
+21,693
+20% +$182K
AIR icon
1142
AAR Corp
AIR
$5.77B
$1.45M 0.01%
19,951
+2,717
+16% +$184K
CALM icon
1143
Cal-Maine
CALM
$3.87B
$1.45M 0.01%
23,689
+2,918
+14% +$173K
SMG icon
1144
ScottsMiracle-Gro
SMG
$3.59B
$1.44M 0.01%
22,140
-2,632
-11% -$180K
TGTX icon
1145
TG Therapeutics
TGTX
$7.34B
$1.43M 0.01%
80,608
+8,286
+11% +$132K
CCOI icon
1146
Cogent Communications
CCOI
$530M
$1.43M 0.01%
25,381
+3,253
+15% +$194K
RIOT icon
1147
Riot Platforms
RIOT
$7.21B
$1.43M 0.01%
156,634
+55,511
+55% +$560K
JJSF icon
1148
J&J Snack Foods
JJSF
$1.7B
$1.43M 0.01%
8,814
+1,272
+17% +$195K
GFF icon
1149
Griffon
GFF
$4.8B
$1.43M 0.01%
22,357
+2,258
+11% +$153K
CBU icon
1150
Community Bank
CBU
$3.46B
$1.42M 0.01%
30,165
+2,868
+11% +$130K

Similar funds

MetLife Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, MetLife Investment Management held 2,964 positions worth $16.8B, up 13% from $14.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

MetLife Investment Management deployed $1.49B of net new capital in Q2 2024, opening 179 new positions and adding to 2,266 existing holdings. Its largest new stake was GE Vernova: 73,079 shares worth $12.5M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $92.7M trimmed.

  • MetLife Investment Management's largest Q2 2024 buy was GE Vernova: 73,079 shares worth $12.5M.
  • MetLife Investment Management added most to Microsoft in Q2 2024, an estimated $118M increase.
  • MetLife Investment Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $92.7M.
  • MetLife Investment Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $14.4M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $16.8B portfolio in Q2 2024.
  • MetLife Investment Management opened 179 new positions and closed 84 in Q2 2024.
  • MetLife Investment Management's portfolio value rose 13% quarter-over-quarter to $16.8B.

Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.